|
|
Blood, 1 October 2005, Vol. 106, No. 7, pp. 2259-2268.
Prepublished online as a Blood First Edition Paper on June 7, 2005; DOI 10.1182/blood-2005-03-1189.
 Previous Article | Table of Contents | Next Article 
CHEMOKINES
Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology
Renata Sano,
Alessandra Tessitore,
Angela Ingrassia, and
Alessandra d'Azzo
From the Department of Genetics and Tumor Cell Biology, Saint Jude Children's Research Hospital, Memphis, TN.
Bone marrow cells (BMCs) could correct some pathologic conditions of the central nervous system (CNS) if these cells would effectively repopulate the brain. One such condition is GM1-gangliosidosis, a neurodegenerative glycosphingolipidosis due to deficiency of lysosomal  -galactosidase (-gal). In this disease, abnormal build up of GM1-ganglioside in the endoplasmic reticulum of brain cells results in calcium imbalance, induction of an unfolded protein response (UPR), and neuronal apoptosis. These processes are accompanied by the activation/proliferation of microglia and the production of inflammatory cytokines. Here we demonstrate that local neuroinflammation promotes the selective activation of chemokines, such as stromal-cell-derived factor 1 (SDF-1), macrophage inflammatory protein 1- (MIP-1), and MIP-1, which chemoattract genetically modified BMCs into the CNS. Mice that underwent bone marrow transplantation showed increased -gal activity in different brain regions and reduced lysosomal storage. Decreased production of chemokines and effectors of the UPR as well as restoration of neurologic functions accompanied this phenotypic reversion. Our results suggest that -gal-expressing bone marrow (BM)-derived cells selectively migrate to the CNS under a gradient of chemokines and become a source of correcting enzyme to deficient neurons. Thus, a disease condition such as GM1-gangliosidosis, which is characterized by neurodegeneration and neuroinflammation, may influence the response of the CNS to ex vivo gene therapy.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. L. Zozulya, E. Reinke, D. C. Baiu, J. Karman, M. Sandor, and Z. Fabry
Dendritic Cell Transmigration through Brain Microvessel Endothelium Is Regulated by MIP-1{alpha} Chemokine and Matrix Metalloproteinases
J. Immunol.,
January 1, 2007;
178(1):
520 - 529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
